Literature DB >> 26853890

Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping.

Xiaojun Guan1, Min Xuan1, Quanquan Gu1, Peiyu Huang1, Chunlei Liu2,3, Nian Wang2, Xiaojun Xu1, Wei Luo4, Minming Zhang1.   

Abstract

The progression of Parkinson's disease (PD) seems to vary according to the disease stage, which greatly influences the management of PD patients. However, the underlying mechanism of progression in PD remains unclear. This study was designed to explore the progressive pattern of iron accumulation at different stages in PD patients. Sixty right-handed PD patients and 40 normal controls were recruited. According to the disease stage, 45 patients with Hoehn-Yahr stage ≤ 2.5 and 15 patients with Hoehn-Yahr stage ≥ 3 were grouped into early-stage PD (EPD) and late-stage PD (LPD) groups, respectively. The iron content in the cardinal subcortical nuclei covering the cerebrum, cerebellum and midbrain was measured using quantitative susceptibility mapping (QSM). The substantia nigra pars compacta (SNc) showed significantly increased QSM values in the EPD patients compared with the controls. In the LPD patients, while the SNc continued to show increased QSM values compared with the controls and EPD patients, the regions showing increased QSM values spread to include the substantia nigra pars reticulata (SNr), red nucleus (RN) and globus pallidus (GP). Our data also indicated that iron deposition was more significant in the GP internal segment (GPi) than in the GP external segment. No other regions showed significant changes in QSM values among the groups. Therefore, we were able to confirm a regionally progressive pattern of iron accumulation in the different stages of PD, indicating that iron deposition in the SNc is affected exclusively in the early stages of the disease, while the SNr, RN and GP, and particularly the GPi segment, become involved in advanced stages of the disease. This is a preliminary study providing objective evidence of the iron-related progression in PD.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Parkinson's disease; disease stage; iron; progression; quantitative susceptibility mapping

Mesh:

Substances:

Year:  2016        PMID: 26853890      PMCID: PMC4977211          DOI: 10.1002/nbm.3489

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  37 in total

1.  Internal structures of the globus pallidus in patients with Parkinson's disease: evaluation with quantitative susceptibility mapping (QSM).

Authors:  Satoru Ide; Shingo Kakeda; Issei Ueda; Keita Watanabe; Yu Murakami; Junji Moriya; Atsushi Ogasawara; Koichiro Futatsuya; Toru Sato; Norihiro Ohnari; Kazumasa Okada; Atsuji Matsuyama; Hitoshi Fujiwara; Masanori Hisaoka; Sadatoshi Tsuji; Tian Liu; Yi Wang; Yukunori Korogi
Journal:  Eur Radiol       Date:  2014-11-01       Impact factor: 5.315

2.  Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence.

Authors:  J M Graham; M N Paley; R A Grünewald; N Hoggard; P D Griffiths
Journal:  Brain       Date:  2000-12       Impact factor: 13.501

3.  Whole brain susceptibility mapping using compressed sensing.

Authors:  Bing Wu; Wei Li; Arnaud Guidon; Chunlei Liu
Journal:  Magn Reson Med       Date:  2011-06-10       Impact factor: 4.668

Review 4.  Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain.

Authors:  Chunlei Liu; Wei Li; Karen A Tong; Kristen W Yeom; Samuel Kuzminski
Journal:  J Magn Reson Imaging       Date:  2014-10-01       Impact factor: 4.813

5.  MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects.

Authors:  G Bartzokis; J L Cummings; C H Markham; P Z Marmarelis; L J Treciokas; T A Tishler; S R Marder; J Mintz
Journal:  Magn Reson Imaging       Date:  1999-02       Impact factor: 2.546

6.  Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times.

Authors:  Ying Jiao Zhao; Hwee Lin Wee; Yiong-Huak Chan; Soo Hoon Seah; Wing Lok Au; Puay Ngoh Lau; Emmanuel Camara Pica; Shu Chuen Li; Nan Luo; Louis C S Tan
Journal:  Mov Disord       Date:  2010-04-30       Impact factor: 10.338

Review 7.  Neurodegenerative diseases and therapeutic strategies using iron chelators.

Authors:  Roberta J Ward; David T Dexter; Robert R Crichton
Journal:  J Trace Elem Med Biol       Date:  2015-01-22       Impact factor: 3.849

8.  Midbrain iron content in early Parkinson disease: a potential biomarker of disease status.

Authors:  W R Wayne Martin; Marguerite Wieler; Myrlene Gee
Journal:  Neurology       Date:  2008-01-02       Impact factor: 9.910

9.  Brain iron accumulation exacerbates the pathogenesis of MPTP-induced Parkinson's disease.

Authors:  L-H You; F Li; L Wang; S-E Zhao; S-M Wang; L-L Zhang; L-H Zhang; X-L Duan; P Yu; Y-Z Chang
Journal:  Neuroscience       Date:  2014-10-06       Impact factor: 3.590

10.  MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease.

Authors:  Paraskevi Kosta; Maria I Argyropoulou; Sofia Markoula; Spyridon Konitsiotis
Journal:  J Neurol       Date:  2005-06-29       Impact factor: 6.682

View more
  39 in total

1.  Using Phase Data From MR Temperature Imaging to Visualize Anatomy During MRI-Guided Focused Ultrasound Neurosurgery.

Authors:  Nathan McDannold; P Jason White; G Rees Cosgrove
Journal:  IEEE Trans Med Imaging       Date:  2020-11-30       Impact factor: 10.048

2.  Neonate and infant brain development from birth to 2 years assessed using MRI-based quantitative susceptibility mapping.

Authors:  Yuyao Zhang; Jingjing Shi; Hongjiang Wei; Victor Han; Wen-Zhen Zhu; Chunlei Liu
Journal:  Neuroimage       Date:  2018-10-10       Impact factor: 6.556

3.  Iron-related nigral degeneration influences functional topology mediated by striatal dysfunction in Parkinson's disease.

Authors:  Xiaojun Guan; Yuyao Zhang; Hongjiang Wei; Tao Guo; Qiaoling Zeng; Cheng Zhou; Jiaqiu Wang; Ting Gao; Min Xuan; Quanquan Gu; Xiaojun Xu; Peiyu Huang; Jiali Pu; Baorong Zhang; Chunlei Liu; Minming Zhang
Journal:  Neurobiol Aging       Date:  2018-11-22       Impact factor: 4.673

Review 4.  Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care.

Authors:  Yi Wang; Pascal Spincemaille; Zhe Liu; Alexey Dimov; Kofi Deh; Jianqi Li; Yan Zhang; Yihao Yao; Kelly M Gillen; Alan H Wilman; Ajay Gupta; Apostolos John Tsiouris; Ilhami Kovanlikaya; Gloria Chia-Yi Chiang; Jonathan W Weinsaft; Lawrence Tanenbaum; Weiwei Chen; Wenzhen Zhu; Shixin Chang; Min Lou; Brian H Kopell; Michael G Kaplitt; David Devos; Toshinori Hirai; Xuemei Huang; Yukunori Korogi; Alexander Shtilbans; Geon-Ho Jahng; Daniel Pelletier; Susan A Gauthier; David Pitt; Ashley I Bush; Gary M Brittenham; Martin R Prince
Journal:  J Magn Reson Imaging       Date:  2017-03-10       Impact factor: 4.813

5.  Different iron deposition patterns in Parkinson's disease subtypes: a quantitative susceptibility mapping study.

Authors:  Junling Chen; Tongtong Cai; Yan Li; Jieshan Chi; Siming Rong; Chentao He; Xiaohong Li; Piao Zhang; Lijuan Wang; Yuhu Zhang
Journal:  Quant Imaging Med Surg       Date:  2020-11

Review 6.  Region-Specific Iron Measured by MRI as a Biomarker for Parkinson's Disease.

Authors:  Xiaojun Guan; Xiaojun Xu; Minming Zhang
Journal:  Neurosci Bull       Date:  2017-05-17       Impact factor: 5.203

Review 7.  Iron metabolism and its detection through MRI in parkinsonian disorders: a systematic review.

Authors:  Sara Pietracupa; Antonio Martin-Bastida; Paola Piccini
Journal:  Neurol Sci       Date:  2017-09-02       Impact factor: 3.307

8.  In vivo magnetic resonance imaging and spectroscopy. Technological advances and opportunities for applications continue to abound.

Authors:  Peter van Zijl; Linda Knutsson
Journal:  J Magn Reson       Date:  2019-07-09       Impact factor: 2.229

9.  [Correlation of cardiovascular risk factors with brain iron deposition: A magnetic resonance imaging study].

Authors:  Linlin Hu; Ruiting Zhang; Shuyue Wang; Hui Hong; Peiyu Huang; Minming Zhang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2019-12-25

10.  Asymmetric susceptibility tensor imaging.

Authors:  Steven Cao; Hongjiang Wei; Jingjia Chen; Chunlei Liu
Journal:  Magn Reson Med       Date:  2021-05-20       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.